OraSure Technologies (NASDAQ:OSUR) PT Lowered to $4.50 at Evercore ISI

OraSure Technologies (NASDAQ:OSUR – Free Report) had its price objective trimmed by Evercore ISI from $5.50 to $4.50 in a report released on Tuesday, Benzinga reports. The brokerage currently has an in-line rating on the medical instruments supplier’s stock. A number of other research firms have also recently commented on OSUR. StockNews.com cut shares of […]

Leave a Reply

Your email address will not be published.

Previous post NovoCure (NASDAQ:NVCR) Price Target Raised to $20.00
Next post Jefferies Financial Group Begins Coverage on Rapport Therapeutics (NASDAQ:RAPP)